Biotech News ButlerBiotech News ButlerBETA
TrendingFeedbackLog In

Trending News in Biotech

Top stories being covered by multiple trusted sources right now

Basecamp launches Trillion Gene Atlas
Basecamp Research startet den Trillion Gene Atlas, um KI-entwickelte Therapeutika zu skalieren— PR Newswire - HealthFREEBasecamp Research lance le Trillion Gene Atlas pour développer des thérapies conçues par l'IA— PR Newswire - HealthFREEAI startup Basecamp Research announces trillion-gene project— Endpoints News
Icotyde gauges oral psoriasis demand
Icotyde may provide clearest test yet of demand for oral psoriasis drugs— BioCenturyWith FDA Approval, Icotyde Wades Into Competitive Psoriasis Market— Citeline - ScripJ&J wins FDA nod for psoriasis pill that aims to compete with top-selling injections— BioPharma DiveFREE
UK MHRA-NICE aligned access pathway
UK MHRA-NICE Aligned Pathway: No Surprise ‘Exam Questions’ For Market Access— Citeline - Pink SheetFirst MHRA/NICE aligned guidance due in June— pharmaphorumFREE
Excalipoint raises $68.7M seed round
Excalipoint closes $68.7M seed round for cancer T-cell engagers— BioWorld (Clarivate)Shanghai biotech Excalipoint gains $68.7M for T cell engagers— Endpoints NewsLilly-Backed China Startup Debuts With $68.7M Seed to Advance Next-Gen T Cell Engagers— BioSpaceFREE
Aldeyra gets third FDA CRL
Aldeyra's dry eye drug gets third rejection from FDA, triggering stock slide— Endpoints NewsAldeyra collects third CRL for reproxalap in dry eye disease— BioWorld (Clarivate)Third FDA Rejection for Aldeyra’s Dry Eye Disease Drug Sends Shares Plummeting— BioSpaceFREE
FDA drafts guidance to reduce animal testing
FDA seeks to encourage fewer animal studies with new draft guidance— Endpoints NewsFDA Releases Draft Guidance on Alternatives to Animal Testing in Drug Development— FDA Press ReleaseFREE
Atrogi doses first subjects for ATR-258
Atrogi begins dosing first subjects in human trial of ATR-258— PharmaTimesFREEAtrogi announces first subjects dosed in human trial for lead candidate ATR-258— PR Newswire - HealthFREE
Federal judge blocks RFK vaccine policy changes
Federal court blocks RFK Jr.’s moves to upend US vaccine policy— BioPharma DiveFREEKennedy’s Vaccine Policy Overhaul Stymied by Federal Judge— BioSpaceFREE
Rhythm’s Imcivree misses Phase 3 in obesity
Focus Shifts To Rhythm’s Imcivree Hypothalamic Obesity Opportunity After Phase III Miss— Citeline - ScripRhythm’s Imcivree fails Phase 3 rare form obesity trial— Endpoints News
Law firm probes ID Care data breach
DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of Persons Affected by the ID Care Data Breach— PR Newswire - HealthFREEDATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of Persons Affected by the ID Care Data Breach— Global News Wire - Licensing Agreement

Updated every few hours. Subscribe to get personalized digests delivered to your inbox.